Virus-like particle vaccines: immunology and formulation for clinical translation-Reference-Cited by-同舟云学术

Virus-like particle vaccines: immunology and formulation for clinical translation

Published:2018-09-02 Issue:9 Volume:17 Page:833-849
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Donaldson Braeden¹²^ORCID,Lateef Zabeen³,Walker Greg F.⁴,Young Sarah L.²,Ward Vernon K.¹^ORCID

Affiliation:

1. Department of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand

2. Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

3. Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand

4. School of Pharmacy, University of Otago, Dunedin, New Zealand

Funder

Prostate Cancer Foundation of New Zealand

Freemasonry New Zealand

University of Otago

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1516552

Reference175 articles.

1. Antigen delivery by virus-like particles for immunotherapeutic vaccination

2. Lachance P, Dionne M, Libman M, et al. Medicago, Inc. Immunogenicity of a quadrivalent virus-like particles (VLP) influenza vaccine in healthy adults. NCT02768805. 2016.

3. Sheldon E, Seiden DJ, Medicago, Inc. Immunogenicity, safety and tolerability of a plant-derived seasonal virus-like-particle quadrivalent influenza vaccine in adults. NCT02233816. 2016.

4. Acevedo-Flores M, Diaz C, Hoen B, et al. National Institute of Allergy and Infectious Diseases (NIAID). Trial for safety and immunogenicity of a chikungunya vaccine, VRC-CHKVLP059-00-VP, in healthy adults. NCT02562482. 2016.

5. Langley J, VBI Vaccines Inc. Study to evaluate safety, tolerability, and immunogenicity of candidate human cytomegalovirus vaccine in healthy adults. NCT02826798. 2016.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic Acid Delivery Nanotechnologies for In Vivo Cell Programming;ACS Applied Bio Materials;2024-01-30

2. Virosome: A vector in vaccine delivery;BIO Web of Conferences;2024

3. Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme;Infection and Immunity;2023-12-12

4. mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions;Vaccines;2023-11-21

5. Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines;Pathogens;2023-10-19